{"id":"https://openalex.org/W2155585300","doi":null,"title":"A phase I study of recombinant interleukin 2 plus recombinant beta-interferon.","display_name":"A phase I study of recombinant interleukin 2 plus recombinant beta-interferon.","publication_year":1988,"publication_date":"1988-07-01","ids":{"openalex":"https://openalex.org/W2155585300","mag":"2155585300","pmid":"https://pubmed.ncbi.nlm.nih.gov/3132324"},"language":"en","primary_location":{"id":"pmid:3132324","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3132324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088153035","display_name":"Robert L. Krigel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1289437631","display_name":"Fox Chase Cancer Center","ror":"https://ror.org/0567t7073","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1289437631","https://openalex.org/I4210122924"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R L Krigel","raw_affiliation_strings":["Department of Medicine, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111","institution_ids":["https://openalex.org/I1289437631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085127834","display_name":"Kristin Padavic\u2010Shaller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K A Padavic-Shaller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109069603","display_name":"Alfred R. Rudolph","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A R Rudolph","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002825676","display_name":"Samuel Litwin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Litwin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"M Konrad","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Konrad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110170216","display_name":"Edward C. Bradley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E C Bradley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110261165","display_name":"Robert L. Comis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R L Comis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.9207,"has_fulltext":false,"cited_by_count":54,"citation_normalized_percentile":{"value":0.91791806,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"48","issue":"13","first_page":"3875","last_page":"81"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5321999788284302,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.5321999788284302,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.11429999768733978,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.06459999829530716,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.8830000162124634},{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.8479999899864197},{"id":"https://openalex.org/keywords/recombinant-interferon","display_name":"recombinant interferon","score":0.6499999761581421},{"id":"https://openalex.org/keywords/lymphokine-activated-killer-cells","display_name":"lymphokine-activated killer cells","score":0.9490000009536743},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.5989999771118164},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8289999961853027},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7889999747276306},{"id":"https://openalex.org/keywords/route-of-administration","display_name":"route of administration","score":0.6209999918937683},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.44200000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8018786907196045},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7141026258468628},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5215827822685242},{"id":"https://openalex.org/C2777371288","wikidata":"https://www.wikidata.org/wiki/Q410130","display_name":"Interleukin 2","level":3,"score":0.5087352395057678},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.505448579788208},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.47201961278915405},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4656902551651001},{"id":"https://openalex.org/C49382859","wikidata":"https://www.wikidata.org/wiki/Q286498","display_name":"Lymphokine","level":3,"score":0.4195408821105957},{"id":"https://openalex.org/C2779802037","wikidata":"https://www.wikidata.org/wiki/Q40878","display_name":"Diarrhea","level":2,"score":0.41728100180625916},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3916794955730438},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3378475308418274},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.3193373382091522},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.11758214235305786}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007111","descriptor_name":"Immunity, Cellular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007370","descriptor_name":"Interferon Type I","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:3132324","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3132324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2155585300","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3132324","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W153538655","https://openalex.org/W197994193","https://openalex.org/W1457890396","https://openalex.org/W1486207857","https://openalex.org/W1494320849","https://openalex.org/W1496465423","https://openalex.org/W1506157243","https://openalex.org/W1544808474","https://openalex.org/W1577005558","https://openalex.org/W1667574047","https://openalex.org/W1911184062","https://openalex.org/W1952620523","https://openalex.org/W1977096306","https://openalex.org/W2016908588","https://openalex.org/W2021977722","https://openalex.org/W2034052948","https://openalex.org/W2049822454","https://openalex.org/W2084855813","https://openalex.org/W2154856945","https://openalex.org/W2320184537","https://openalex.org/W2322553446","https://openalex.org/W2326245275","https://openalex.org/W2410655856","https://openalex.org/W2416781326","https://openalex.org/W2420056077","https://openalex.org/W2460460274"],"related_works":["https://openalex.org/W2417902249","https://openalex.org/W1563242771","https://openalex.org/W1549036085","https://openalex.org/W1782196071","https://openalex.org/W2084215119","https://openalex.org/W2108162873","https://openalex.org/W1977445553","https://openalex.org/W2025681648","https://openalex.org/W2412085883","https://openalex.org/W2417239290"],"abstract_inverted_index":{"Interleukin":[0],"2":[1],"(IL-2)":[2],"therapies":[3],"have":[4],"antitumor":[5,238],"activities":[6,13],"against":[7],"several":[8],"neoplasms.":[9],"In":[10],"vitro":[11],"these":[12],"are":[14,245],"enhanced":[15],"by":[16,247],"beta-interferon":[17],"(IFN-beta).":[18],"Therefore,":[19],"we":[20],"initiated":[21],"a":[22,27,149,156,196],"Phase":[23,268],"I":[24],"trial":[25],"with":[26,191,236],"combination":[28,82],"of":[29,60,62,90,97,139,177,206,243,276,283],"IL-2":[30,43,52,64,91,214,224,252,277],"and":[31,57,92,109,123,152,171,250,253,263],"IFN-beta":[32,37,254],"three":[33,146,256],"times":[34,257],"weekly.":[35],"The":[36,76,266],"was":[38,44,65,165],"administered":[39,45],"i.v.":[40,68,84,213,222,259],"Initially,":[41],"the":[42,51,58,63,74,81,212],"s.c.":[46],"However,":[47],"neutralizing":[48],"antibody":[49],"to":[50,67],"developed":[53],"in":[54,167],"five":[55],"patients,":[56],"route":[59],"administration":[61],"changed":[66],"Forty-seven":[69],"patients":[70,131,142,147,169],"were":[71,85,101,126,132],"entered":[72],"on":[73],"study.":[75],"maximum":[77],"tolerated":[78],"doses":[79],"for":[80,134],"given":[83,255],"5":[86,173,272],"x":[87,94,174,273,280],"10(6)":[88,95,175,274,281],"units/m2":[89,96,176,275,282],"10":[93],"IFN-beta.":[98,284],"Dose-limiting":[99],"toxicities":[100],"profound":[102],"fatigue/decreased":[103],"performance":[104],"status,":[105],"anorexia/weight":[106],"loss,":[107],"depression,":[108],"arthralgias.":[110],"Hypotension,":[111],"exfoliative":[112],"skin":[113],"rash,":[114],"thrombocytopenia,":[115],"diarrhea,":[116],"temperature":[117],"greater":[118],"than":[119,189,203],"40.6":[120],"degrees":[121],"C,":[122],"peripheral":[124],"edema":[125],"rarely":[127],"dose":[128,270],"limiting.":[129],"Thirty-two":[130],"evaluable":[133],"response.":[135,158,197],"After":[136],"4":[137,209],"weeks":[138],"treatment,":[140],"21":[141],"had":[143,148,155,181,184],"stable":[144,193],"disease,":[145],"minor":[150],"response,":[151,239],"one":[153],"patient":[154],"partial":[157],"Significant":[159],"lymphokine-activated":[160],"killer":[161],"cell":[162],"(LAK)":[163],"activity":[164,188,232],"seen":[166],"seven":[168],"(22%)":[170],"required":[172],"IL-2.":[178],"Those":[179],"who":[180],"progressive":[182],"disease":[183,194],"significantly":[185],"less":[186],"LAK":[187,228,231],"those":[190],"either":[192],"or":[195],"This":[198,216],"therapy":[199,225],"also":[200],"induced":[201,246],"more":[202],"60":[204],"units/ml":[205],"endogenous":[207],"gamma-interferon":[208,244],"h":[210],"after":[211],"administration.":[215],"study":[217],"demonstrates":[218],"that":[219],"(a)":[220],"intermittent":[221],"bolus":[223],"can":[226],"generate":[227],"activity,":[229],"(b)":[230],"may":[233],"be":[234],"associated":[235],"an":[237],"(c)":[240],"significant":[241],"levels":[242],"this":[248],"therapy,":[249],"(d)":[251],"weekly":[258],"is":[260,271],"both":[261],"tolerable":[262],"biologically":[264],"active.":[265],"recommended":[267],"II":[269],"plus":[278],"6":[279]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}